tesamorelin with ipamorelin 2X Blend & Tesamorelin Peptide Injectable – Boost

In October 2023, the FDA designated CJC-1295 and Ipamorelin as Category 2 bulk drug substances effectively prohibiting them from being compounded by licensed pharmacies for human use

day 52: p = 0.0363)

Tesamorelin can be injected at any time of day

REM-Window Optimization: It is designed to capitalize on the nightly repair cycle, the specific time when your body performs the majority of its cellular regeneration

8 weeks: ~4 vials 12 weeks: ~6 vials 16 weeks: ~8 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (5-on/2-off): ~40 syringes 16 weeks: ~80 syringes Bacteriostatic Water (10 mL bottles) Use 2.03.0 mL per 10 mg vial for reconstitution